Newsroom

Ever wondered how a brilliant scientific idea is transformed from lab findings to a new biotech start-up…and eventually to new medicines that can impact millions of patients’ lives? In this podcast, we peel back the covers on the early stages of this process through telling the story of Belharra Therapeutics, a promising chemoproteomics company seeking to lead a new wave of drug discovery. Belharra launched just one year ago from an idea that germinated at The Scripps Research Institute, was incubated and supported by Versant Ventures, and its potential validated by a multi-year collaboration with a major biotech company.

Hosted by Belharra CEO Jeff Jonker and featuring conversations with the company’s founders, investors, and team members, this podcast provides an inside peek at the birth and early evolution of a biotech while the story is still emerging and taking shape. Tune in!